Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450

Molecular Pharmacology

Volumn 49, Issue 5, 1996, Pages 796-801

  Carlson, Timothy J ^a   Billing, Ruth E ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOKINE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRIAZENE DERIVATIVE;

ACUTE PHASE RESPONSE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG METABOLISM; KUPFFER CELL; LIVER CELL; LIVER METABOLISM; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; ISOENZYMES; LIVER; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029865859     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Mannering, G. J., and L. B. Deloria. The pharmacology and toxicology of interferons: an overview. Annu. Rev. Pharmacol. Toxicol. 26:455-515 (1986).
2. Renton, K. W. Relationships between the enzymes of detoxication and host defense mechanisms, in Biological Basis of Detoxication (J. Caldwell and W. B. Jakoby, eds.). Academic Press, New York, 307-324 (1983).
3. Andus, T., J. Bauer, and W. Gerok. Effects of cytokines on the liver. Hepatology 13:364-375 (1991).
4. Ghezzi, P . B. Saccardo, and M. Bianchi. Recombinant tumor necrosis factor depresses cytochrome P-450-dependent microsomal drug metabolism in mice. Biochem. Biophys. Res. Commun. 136:316-321 (1986).
5. Bertini, R., M. Bianchi, P. Villa, and P. Ghezzi. Depression of liver drug metabolism and increase in plasma fibrinogen by interleukin-1 and tumor necrosis factor: a comparison with lymphotoxin and interferon. Int. J. Immunopharmacol 10:525-530 (1988).
6. Sujita, K., F. Okuno, Y. Tanaka, Y. Tanaka, Y Hirano, Y. Inamoto, S. Eto, and M. Arai. Effect of interleukin-1 (IL-1) on the levels of cytochrome P-450 involving IL-1 receptor on the isolated hepatocytes of rat. Biochem. Biophys. Res. Commun. 168:1217-1222 (1990).
7. Wright, K., and E. T. Morgan. Regulation of cytochrome P-450IIC12 expression by interleukin-1α, interleukin-6, and dexamethasone. Mol. Pharmacol 39:468-474 (1991).
8. Barker, C. W., J. B. Fagan, and D. S. Pasco. Interleukin-1β suppresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes. J. Biol. Chem. 267:8050-8055 (1992).
9. Abdel-Razzak, Z., P. Loyer, A. Fautrel, J.-C. Gautier, L. Corcos, B. Turlin, P. Beaune, and A. Guillouzo. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol. Pharmacol. 44:707-715 (1993).
10. Pous, C., J.-P. Giroud, C. Damais, D. Raichvarg, and L. Chauvelot-Moachan. Effect of recombinant human interleukin-1β and tumor necrosis factor on liver cytochrome P-450 and serum-1-acid glycoprotein concentrations in the rat. Drug Metab. Dispos. 18:467-470 (1990).
11. Shedlofsky, S. I., A. T. Swim, J. M. Robinson, V. S. Gallicchio, D. A. Cohen, and C. J. McClain. Interleukin-1 (IL-1) depresses cytochrome P-450 levels and activities in mice. Life Sci. 40:2331-2336 (1987).
12. Ferrari, L., P. Dremers, A.-M. Batt, J. E. Gielen, and G. Siest. Differential effects of human recombinant interleukin-1β on cytochrome P-450- dependent activities in cultured fetal rat hepatocytes. Drug Metab. Dispos. 20:407-412 (1992).
13. Chen, Y. L., I. Florentin, A.-M. Batt, L. Ferrari, J. P. Giroud, and L. Chauvelot-Moachan Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat. Biochem. Pharmacol. 44: 137-148 (1992).
14. Williams, J. F., W. J. Bement, J. F. Sinclair, and P. S. Sinclair. Effect of interleukin-6 on phenobarbital induction of cytochrome P-450IIB in cultured rat hepatocytes. Biochem. Biophys. Res. Commun. 178:1049-1055 (1991).
15. Nussler, A., M. DiSilvio, T. Billiar, R. Hoffman, D. Geller, R. Selby, J. Madariaga, and R. Simmons. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 176:261-264 (1992).
16. Adamson, G. M., and R. E. Billings. Cytokine toxicity and induction of NO synthase activity in cultured mouse hepatocytes. Toxicol. Appl. Pharmacol. 119:100-107 (1993).
17. Wink, D. A., Y. Osawa, J. F. Darbyshire, C. R. Junes, S. C. Eshenaur, and R. W. Nims. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys. 300:115-123 (1993).
18. Khatsenko, O. G., S. S. Gross, A. B. Rifkind, and J. R. Vane. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl. Acad. Sci. USA 90:11147-11151 (1993).
19. Stadler, J., J. Trockfeld, W. A. Schmalix, T. Brill, J. R. Siewert, H. Grein, and J. Doehmer. Inhibition of cytochromes P4501A by nitric oxide. Proc. Natl. Acad. Sci. USA 91:3559-3563 (1994).
20. Ku, R. H., and R. E. Billings. The role of mitochondrial glutathione and cellular protein sulfhydyls in formaldehyde toxicity in glutathione depleted rat hepatocytes. Arch. Biochem. Biophys. 247:183-189 (1986).
21. Peterson, L. A., A. Trevor, and N. Castagnoli, Jr. Stereochemical studies on the cytochrome P-450 catalyzed oxidation of (S)-nicotine to the (S)-nicotine-1′,5′-iminium species. J. Med. Chem. 30:249-254 (1987).
22. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
23. Omura, T., and K. Sato. The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239:2370-2378 (1964).
24. Page, D., and J. Garvey. Isolation and characterization of hepatocytes and Kupffer cells. J. Immunol. Methods 27:159-173 (1979).
25. Ding, A. H., C. F. Nathan, and D. J. Stuehr. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse intraperitoneal macrophages: comparison of activating cytokines and evidence for independent production J. Immunol. 141:2407-2412 (1988).
26. Schmidt, H. H. H. W., B. Zernikow, S. Baeblich, and E. Bohme. Basal and stimulated formation and release of L-arginine-derived nitrogen oxides from cultured endothelial cells. J. Pharmacol. Exp. Ther. 254:591-597 (1990).
27. Hrabie, J. A., J. R. Hose, D. A. Wink, and L. K. Keefer: New nitric oxide-releasing zwitterions derived from polyamines. J. Org. Chem. 58: 1472-1476 (1993).
28. Shimaoka, M., T. Iida, A. Ohara, N. Taenaka, T. Mashimo, T. Honda, and I. Yoshiya. NOC, a nitric oxide-releasing compound, induces dose dependent apoptosis in macrophages. Biochem. Biophys. Res. Commun. 209: 519-526 (1995).
29. Kuwahara, S. K., and G. J. Mannering, Effects of polyriboinosinic acid-polytibocytidilic acid and steroids on the cytochrome P450 system of cultured primary hepatocytes. Pharmacol. Toxicol. 72:199-204 (1993).
30. Jeong, H. G., T. C. Jeong, and K.-H. Yang. Mouse interferon γ pretreated hepatocytes conditioned media suppress cytochrome P-450 induction by TCDD in mouse hepatoma cells. Biochem. Mol. Biol. Int. 29:197-202 (1993).
31. Duval, D. L., D. J. Sieg, and R. E. Billings. Regulation of hepatic nitric oxide synthase by reactive oxygen intermediates and glutathione. Arch. Biochem. Biophys. 316:699-706 (1995).
32. Ebel, R. E., D. H. O'Keeffe, and J. A. Peterson. Nitric oxide complexes of cytochrome P450. FEBS Lett. 55:198-201 (1975).
33. Young-Myeong, K., H. A. Bergonia, C. Muller, B. R. Pitt, W. D. Watkins, and J. R. Lancaster, Jr. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J. Biol. Chem. 270:5710-5713 (1995).
34. Correia, M. A, K. Sugiyama, and K Yao. Degradation of rat hepatic cytochrome P-450p. Drug Metab. Rev. 20:615-628 (1989).